NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE139302 Query DataSets for GSE139302
Status Public on Oct 24, 2019
Title Lysophosphatidic acid treatment improves brush border maturation and apical SGLT1 activity in Myo5b deficient mice, a model of MVID
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Myosin Vb (Myo5b) is an essential trafficking protein for membrane recycling in gastrointestinal (GI) epithelial cells and its inactivating mutation causes the congenital diarrheal disease, microvillus inclusion disease (MVID). We previously reported that Myo5b deficiency in mice causes mislocalization of SGLT1 and NHE3, but retained apical function of CFTR, resulting in malabsorption and secretory diarrhea. Activation of lysophosphatidic acid (LPA) receptors can improve diarrhea, but the effects of LPA on MVID symptoms is unclear. We therefore tested whether LPA treatment can ameliorate the epithelial deficits in Myo5b knockout (KO) mice. Methods: Adult tamoxifen-induced, intestine-specific, Myo5b KO (VillinCreERT2;Myo5bflox/flox) and littermate control mice were treated with LPA, an LPAR2 agonist (GRI977143), or vehicle for 4 days after a single tamoxifen injection. Apical SGLT1 and CFTR activities were measured in √ússing chambers. The localization of membrane transporters was evaluated by immunostaining in mouse tissues and enteroids. RNA sequencing and enrichment analysis were performed with isolated jejunal epithelial cells. Results: Daily treatment with LPA decreased the frequency of multivesicular bodies and the expression of cathepsins, but did not affect the formation of microvillus inclusions in Myo5b KO mice. LPA partially restored the brush border height and the localization of SGLT1 and NHE3 in Myo5b KO small intestine and enteroids. SGLT1-dependent short-circuit current (Isc) was increased and abnormal CFTR activities were suppressed in LPA-treated jejunum compared to that of vehicle-treated Myo5b KO mice. Conclusions: Cell autonomous LPA signaling may modulate a Myo5b-independent trafficking mechanism and the brush border maturation, demonstrating a therapeutic potential for LPA in the treatment of MVID.
 
Overall design Adult male VillinCreERT2;MYO5Bflox/flox mice were given a single dose of 2 mg of tamoxifen (KO, 7 mice) or corn oil (control, 3 mice) by ip injection. Induced KO mice were treated with LPA (3 mice) or vehicle (4 mice) by ip for 4 days. All mice were euthanized on day 4 and epithelial cells were mechanically isolated from jejunum by micro forceps in ice-cold PBS containing 10 mM EDTA and immersed in TRIzol Reagent (Invitrogen 15596018). RNA was extracted according to the manufacture instructions and RNA-seq was performed by Novogene Corporation Inc. (Sacramento, CA) on 3 or 4 independent preparations from each condition.
 
Contributor(s) Kaji I, Goldenring JR
Citation(s) 34197342
Submission date Oct 23, 2019
Last update date Sep 14, 2021
Contact name Izumi Kaji
E-mail(s) izumi.kaji@vumc.org
Organization name Vanderbilt University Medical Center
Department Surgery
Street address Rm 10465H, MRB IV
City Nashville
State/province TN
ZIP/Postal code 37232
Country USA
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (10)
GSM4137618 Non_KO2
GSM4137619 Non_KO4
GSM4137620 Non_KO5
Relations
BioProject PRJNA579150
SRA SRP226727

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE139302_GEO_seq_spreadsheet_101819IK.xlsx 48.8 Kb (ftp)(http) XLSX
GSE139302_RNA-seq_M5B_induced_selected_101819.xlsx 40.2 Kb (ftp)(http) XLSX
GSE139302_Tmx_KOvsNon_KO_all.GOenrich.significant_metabolism.xlsx 34.0 Kb (ftp)(http) XLSX
GSE139302_Tmx_KOvsNon_KO_down.GOenrich.significant.metabolism.xlsx 21.2 Kb (ftp)(http) XLSX
GSE139302_Tmx_KOvsNon_KO_down.KEGGenrich.significant.txt.gz 2.1 Kb (ftp)(http) TXT
GSE139302_Tmx_KOvsNon_KO_up.GOenrich.significant.metabolic.xlsx 38.3 Kb (ftp)(http) XLSX
GSE139302_Tmx_KOvsNon_KO_up.KEGGenrich.significant.txt.gz 594 b (ftp)(http) TXT
GSE139302_fpkm_genename.txt.gz 2.1 Mb (ftp)(http) TXT
GSE139302_ipL_KOvsTmx_KO_DEG_up.txt.gz 1.4 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap